# Block-replacement Therapy During Radioiodine Therapy

> **NCT00150124** · PHASE4 · COMPLETED · sponsor: **Steen Bonnema** · enrollment: 100 (actual)

## Conditions studied

- Toxic Nodular Goitre
- Graves' Disease

## Interventions

- **DRUG:** MTZ+LT4
- **DRUG:** Methimazole

## Key facts

- **NCT ID:** NCT00150124
- **Lead sponsor:** Steen Bonnema
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-12
- **Final completion:** 2009-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150124, "Block-replacement Therapy During Radioiodine Therapy". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00150124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*